About
Cell Culture Products
Areas of Focus
Categories
Non-PharmaceuticalNorth & South Carolina
Clinical Trials (3)
View allTotal Trials
3
As Lead Sponsor
0
As Collaborator
3
Total Enrollment
98
By Phase
PHASE2: 3
By Status
COMPLETED: 2TERMINATED: 1
Clinical Trials Pipeline3 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2005
2006
2007
2008
2009
2010
2011
Today
Hover over trial bars to see details
Recent Trials
NCT00522457Collaborator
Phase II Study With the Trifunctional Antibody Ertumaxomab to Treat Metastatic Breast Cancer After Progression on Trastuzumab Therapy
PHASE2Terminated
19 participants
Started: Jan 31, 2008 · Completed: Dec 31, 2009
NCT00377429Collaborator
Safety and Efficacy Study of Catumaxomab to Treat Ovarian Cancer After a Complete Response to Chemotherapy
PHASE2Completed
47 participants
Started: Sep 30, 2006 · Completed: Feb 29, 2008
NCT00326885Collaborator
Study of the Trifunctional Antibody Catumaxomab to Treat Recurrent Symptomatic Malignant Ascites
PHASE2Completed
32 participants
Started: Jun 30, 2006 · Completed: Aug 31, 2010
Locations (1)
Headquarters
Monroe, NC, United States
Map
Loading map...